Skip to main content

Year: 2023

Form 8.3 – [Sopheon plc – Opening Declaration – 31 03 2023] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SOPHEON PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Brookfield Infrastructure Reports Third Quarter 2023 Results

BROOKFIELD, NEWS, Nov. 01, 2023 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the third quarter ended September 30, 2023. “We had strong financial results and delivered on all of our strategic initiatives to date in 2023,” said Sam Pollock, Chief Executive Officer of Brookfield Infrastructure Partners. “We have demonstrated our ability to use our size, scale and diversification to continue recycling capital at good valuations, while investing at higher returns on our new investments.”  For the three monthsended September 30   For the nine monthsended September 30US$ millions (except per unit amounts), unaudited1   2023     2022     2023     2022  Net income2 $ 104   $ 113   $ 505   $ 359  – per...

Continue reading

Verisk Reports Third-Quarter 2023 Financial Results

Consolidated revenues were $677.6 million, up 11.1%, and up 9.4% on an organic constant currency (OCC) basis for the third quarter of 2023 reflecting strong growth in underwriting and claims. Income from continuing operations was $187.4 million, up 13.1% for the third quarter of 2023. Adjusted EBITDA, a non-GAAP measure, was $366.0 million, up 12.5%, and up 11.8% on an OCC basis.  Diluted GAAP earnings per share from continuing operations (diluted EPS) were $1.29 for the third quarter of 2023, up 22.9%. Diluted adjusted earnings per share (diluted adjusted EPS), a non-GAAP measure, were $1.52, up 26.7%. Diluted adjusted EPS growth reflects strong revenue and profit growth and the benefit from our accelerated share repurchase program. Net cash provided by operating activities was $250.1 million, down 10.7% and free cash flow, a non-GAAP...

Continue reading

Generac Reports Third Quarter 2023 Results

Return to margin expansion and strong free cash flow generation; maintaining overall net sales and adjusted EBITDA outlook for full-year 2023 WAUKESHA, Wis., Nov. 01, 2023 (GLOBE NEWSWIRE) — Generac Holdings Inc. (NYSE: GNRC) (“Generac” or the “Company”), a leading global designer and manufacturer of energy technology solutions and other power products, today reported financial results for its third quarter ended September 30, 2023 and provided an update on its outlook for the full year 2023. Third Quarter 2023 HighlightsNet sales decreased 2% to $1.07 billion during the third quarter of 2023 as compared to $1.09 billion in the prior-year third quarter. Core sales growth, which excludes both the impact of acquisitions and foreign currency, decreased approximately 4%.Residential product sales declined 15% to $565 million as...

Continue reading

Athabasca Oil Announces 2023 Third Quarter Results with Record Adjusted Funds Flow, Free Cash Flow and Leismer Production along with Continued Share Buybacks

CALGARY, Alberta, Nov. 01, 2023 (GLOBE NEWSWIRE) — Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to report its third quarter results highlighted by record Adjusted Funds Flow and Free Cash Flow, operational momentum at Leismer and execution on its return of capital commitment through share repurchases. Athabasca is uniquely positioned as a low leveraged company generating significant Free Cash Flow through its low-decline, oil weighted asset base. Q3 2023 and Recent Corporate HighlightsProduction: ~36,200 boe/d (95% Liquids); ~31,700 bbl/d in Thermal Oil and ~4,500 boe/d in Light Oil. Record Production at Leismer: 24,232 bbl/d during the quarter following the ramp-up of Pad L8M with five sustaining well pairs. The Company’s expansion project is on track for growth to 28,000 bbl/d in mid-2024 and...

Continue reading

Radware Reports Third Quarter 2023 Financial Results

Third Quarter 2023 Financial Results and HighlightsRevenue of $61.6 million, down 13% year–over–year Cloud ARR of $62.5 million, up 25% year-over-year Non-GAAP EPS of $0.07; GAAP net loss per diluted share of $0.16TEL AVIV, Israel, Nov. 01, 2023 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, today announced its consolidated financial results for the third quarter ended September 30, 2023. “During the third quarter of 2023, our cloud ARR growth accelerated to 25%,” said Roy Zisapel, Radware’s president and CEO. “Going forward, we intend to continue to focus on growing the cloud security business. Combined with cautious optimism regarding the recovery of our appliance business and prudent cost management, we believe we will emerge stronger from...

Continue reading

Axalta Releases Third Quarter 2023 Results

GLEN MILLS, Pa., Nov. 01, 2023 (GLOBE NEWSWIRE) — Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights:Net sales increased 5.7% year-over-year to $1.3 billion Income from operations increased $40 million year-over-year to $163 million and Adjusted EBIT increased $40 million year-over-year to $188 million Operating margins increased 250 bps year-over-year and Adjusted EBIT margin improved 240 bps year-over-year Cash provided by operating activities of $210 million and Free Cash Flow of $182 million Repurchased $50 million of common shares; repriced term loan and improved pricing by 50 bps Increased full year 2023 earnings outlookThird Quarter 2023 Consolidated Financial Results Third...

Continue reading

Lavoro Reports Fiscal Fourth Quarter 2023 Earnings Results

Lavoro’s revenue reached $1.8 billion for the FY2023, marking a 24% increase compared to the previous yearFY2023 gross profit was $332 million, up 34% y/y, with gross margins expanding 140 bps to 18.5% Lavoro successfully completed the acquisition of Referência Agroinsumos on July 31, 2023, further expanding its retail presence in the State of Rio Grando do Sul in the South of Brazil. Referência serves over 2,000 farmers, and brings an additional 25 technical sales representatives (RTVs) to the Lavoro family On June 30, 2023, Lavoro announced a partnership with Stenon, which will enable us to offer accurate real-time soil analysis to our farmer clients, helping their decision-making and leading to improved agronomic outcomes Lavoro provides its FY2024 outlook, expecting consolidated revenue in the range of $2.0 to $2.3 billion, consolidated...

Continue reading

SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting

– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools – STAMFORD, Conn., Nov. 01, 2023 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the presentation of additional data from the Phase 3 DeFi trial at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting, being held November 1-4, 2023. These data demonstrate the impact of nirogacestat, an investigational gamma secretase inhibitor, on physical and role functioning in adults with desmoid tumors. Data from the DeFi trial demonstrated statistically significant and clinically meaningful improvements...

Continue reading

Lavras Gold appoints Naomi Nemeth to the position of Vice President, Investor Relations

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Lavras Gold Corp. (TSXV: LGC, OTCQB: LGCFF) is pleased to announce the appointment of Naomi Nemeth to the newly created position of Vice President, Investor Relations. Ms. Nemeth will be responsible for building and maintaining a comprehensive investor relations program, for communicating with both institutional and retail investors globally and for furthering the development of Lavras Gold’s business and growth strategy. Ms. Nemeth will work with senior management to implement an aggressive institutional shareholder outreach program in the Americas and Europe, will continue Lavras Gold’s ongoing outreach to valued existing and potential new retail shareholders, and will approach non-traditional potential shareholder groups to generate interest in the Lavras success and growth story. “On...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.